Akdis, M. et al. Interleukins, from 1 to 37, and interferon-γ: receptors, functions, and roles in diseases. J. Allergy Clin. Immunol. 127, 701–721.e1–e70 (2011).

CAS  PubMed  Article  Google Scholar 

Rider, P., Carmi, Y. & Cohen, I. Biologics for targeting inflammatory cytokines, clinical uses, and limitations. Int. J. Cell Biol. 2016, 9259646 (2016).

PubMed  PubMed Central  Article  CAS  Google Scholar 

Donnelly, R. P., Young, H. A. & Rosenberg, A. S. An overview of cytokines and cytokine antagonists as therapeutic agents. Ann. N. Y. Acad. Sci. 1182, 1–13 (2009).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Pires, I. S., Hammond, P. T. & Irvine, D. J. Engineering strategies for immunomodulatory cytokine therapies — challenges and clinical progress. Adv. Ther. https://doi.org/10.1002/adtp.202100035 (2021).

Article  Google Scholar 

Holder, P. G. et al. Engineering interferons and interleukins for cancer immunotherapy. Adv. Drug Deliv. Rev. 182, 114112 (2022).

CAS  PubMed  Article  Google Scholar 

Cunningham, B. C. et al. Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. Science 254, 821–825 (1991).

CAS  PubMed  Article  Google Scholar 

Watowich, S. S., Hilton, D. J. & Lodish, H. F. Activation and inhibition of erythropoietin receptor function: role of receptor dimerization. Mol. Cell Biol. 14, 3535–3549 (1994).

CAS  PubMed  PubMed Central  Google Scholar 

Kossiakoff, A. A. & De Vos, A. M. Structural basis for cytokine hormone-receptor recognition and receptor activation. Adv. Protein Chem. 52, 67–108 (1998).

CAS  PubMed  Article  Google Scholar 

Brooks, A. J. et al. Mechanism of activation of protein kinase JAK2 by the growth hormone receptor. Science 344, 1249783 (2014).

PubMed  Article  CAS  Google Scholar 

Wilmes, S. et al. Mechanism of homodimeric cytokine receptor activation and dysregulation by oncogenic mutations. Science 367, 643–652 (2020).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Glassman, C. R. et al. Structure of a Janus kinase cytokine receptor complex reveals the basis for dimeric activation. Science 376, 163–169 (2022).

CAS  PubMed  Article  Google Scholar 

Ihle, J. N., Witthuhn, B. A., Quelle, F. W., Yamamoto, K. & Silvennoinen, O. Signaling through the hematopoietic cytokine receptors. Annu. Rev. Immunol. 13, 369–398 (1995).

CAS  PubMed  Article  Google Scholar 

O’Shea, J. J. & Plenge, R. JAK and STAT signaling molecules in immunoregulation and immune-mediated disease. Immunity 36, 542–550 (2012).

PubMed  PubMed Central  Article  CAS  Google Scholar 

Levy, D. E. & Darnell, J. E. Jr. Stats: transcriptional control and biological impact. Nat. Rev. Mol. Cell Biol. 3, 651–662 (2002).

CAS  PubMed  Article  Google Scholar 

Morris, R., Kershaw, N. J. & Babon, J. J. The molecular details of cytokine signaling via the JAK/STAT pathway. Protein Sci. 27, 1984–2009 (2018).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Wells, J. A. & de Vos, A. M. Hematopoietic receptor complexes. Annu. Rev. Biochem. 65, 609–634 (1996).

CAS  PubMed  Article  Google Scholar 

Wang, X., Lupardus, P., Laporte, S. L. & Garcia, K. C. Structural biology of shared cytokine receptors. Annu. Rev. Immunol. 27, 29–60 (2009).

PubMed  PubMed Central  Article  CAS  Google Scholar 

Rickert, M., Wang, X., Boulanger, M. J., Goriatcheva, N. & Garcia, K. C. The structure of interleukin-2 complexed with its α receptor. Science 308, 1477–1480 (2005).

CAS  PubMed  Article  Google Scholar 

Boulanger, M. J. & Garcia, K. C. Shared cytokine signaling receptors: structural insights from the gp130 system. Adv. Protein Chem. 68, 107–146 (2004).

CAS  PubMed  Article  Google Scholar 

van Boxel-Dezaire, A. H., Rani, M. R. & Stark, G. R. Complex modulation of cell type-specific signaling in response to type I interferons. Immunity 25, 361–372 (2006).

PubMed  Article  CAS  Google Scholar 

Donnelly, R. P. & Kotenko, S. V. Interferon-λ: a new addition to an old family. J. Interferon Cytokine Res. 30, 555–564 (2010).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Malek, T. R. The biology of interleukin-2. Annu. Rev. Immunol. 26, 453–479 (2008).

CAS  PubMed  Article  Google Scholar 

Lai, Y. & Dong, C. Therapeutic antibodies that target inflammatory cytokines in autoimmune diseases. Int. Immunol. 28, 181–188 (2016).

CAS  PubMed  Article  Google Scholar 

Metcalf, D. Hematopoietic cytokines. Blood 111, 485–491 (2008).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Borden, E. C. et al. Interferons at age 50: past, current and future impact on biomedicine. Nat. Rev. Drug Discov. 6, 975–990 (2007).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Gillis, S. & Smith, K. A. Long term culture of tumour-specific cytotoxic T cells. Nature 268, 154–156 (1977).

CAS  PubMed  Article  Google Scholar 

Morgan, D. A., Ruscetti, F. W. & Gallo, R. Selective in vitro growth of T lymphocytes from normal human bone marrows. Science 193, 1007–1008 (1976).

CAS  PubMed  Article  Google Scholar 

Rosenberg, S. A., Yang, J. C., White, D. E. & Steinberg, S. M. Durability of complete responses in patients with metastatic cancer treated with high-dose interleukin-2: identification of the antigens mediating response. Ann. Surg. 228, 307–319 (1998).

CAS  PubMed  PubMed Central  Article  Google Scholar 

McDermott, D. F. & Atkins, M. B. Application of IL-2 and other cytokines in renal cancer. Expert Opin. Biol. Ther. 4, 455–468 (2004).

CAS  PubMed  Article  Google Scholar 

Legha, S. S., Gianan, M. A., Plager, C., Eton, O. E. & Papadopoulous, N. E. Evaluation of interleukin-2 administered by continuous infusion in patients with metastatic melanoma. Cancer 77, 89–96 (1996).

CAS  PubMed  Article  Google Scholar 

Waldhauer, I. et al. Simlukafusp alfa (FAP-IL2v) immunocytokine is a versatile combination partner for cancer immunotherapy. MAbs 13, 1913791 (2021).

PubMed  PubMed Central  Article  CAS  Google Scholar 

Ptacin, J. L. et al. An engineered IL-2 reprogrammed for anti-tumor therapy using a semi-synthetic organism. Nat. Commun. 12, 4785 (2021).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Arellano, M. & Lonial, S. Clinical uses of GM-CSF, a critical appraisal and update. Biologics 2, 13–27 (2008).

CAS  PubMed  PubMed Central  Google Scholar 

Ng, T., Marx, G., Littlewood, T. & Macdougall, I. Recombinant erythropoietin in clinical practice. Postgrad. Med. J. 79, 367–376 (2003).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Tahtinen, S. et al. Favorable alteration of tumor microenvironment by immunomodulatory cytokines for efficient T-cell therapy in solid tumors. PLoS ONE 10, e0131242 (2015).

PubMed  PubMed Central  Article  CAS  Google Scholar 

Liu, B. L. et al. ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties. Gene Ther. 10, 292–303 (2003).

CAS  PubMed  Article  Google Scholar 

Andtbacka, R. H. I. et al. Final analyses of OPTiM: a randomized phase III trial of talimogene laherparepvec versus granulocyte–macrophage colony-stimulating factor in unresectable stage III–IV melanoma. J. Immunother. Cancer 7, 145 (2019).

PubMed  PubMed Central  Article  Google Scholar 

Pegram, H. J. et al. Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning. Blood 119, 4133–4141 (2012).

CAS  PubMed